Preview | Collaboration Agreement |

Document Preview

Collaboration Agreement

Click "Add to Cart" button to purchase document.
Documents are emailed immediately after purchase.
You can also browse documents by title, category, or company... or click here for help finding documents.

Title:

Collaboration Agreement

Entities:

Sequenom, Inc.

Date:

2004

Size:

83KB total

Price:

$50

ID:

#325824

► Licensing ► Collaboration Agreements
► Biotech & Drugs ► Commercial Physical & Biological Research

Start of Preview

***CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

COLLABORATION AGREEMENT

BETWEEN

SEQUENOM, INC.

AND

PROCTER & GAMBLE PHARMACEUTICALS, INC.

DECEMBER 17, 2003


				*Confidential Treatment Requested

***Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

TABLE OF CONTENTS

(CONTINUED)


			PAGE
1.	Definitions		1

	1.1	Actions	1

	1.2	Active	1

	1.3	Active Compound	1

	1.4	Affiliate	2

	1.5	Claim	2

	1.6	Controlled	2

	1.7	Diagnostic	2

	1.8	Excluded Field	2

	1.9	FDA	2

	1.0	Field	2

	1.1	First Commercial Sale	2

	1.12	Gene Target	2

	1.13	Information	2

	1.14	Initial Research Team	2

	1.15	Invention	2

	1.16	IND	2

	1.17	Joint Inventions	3

	1.18	Joint Patents	3

	1.19	Licensed Product	3

	1.20	NDA	3

	1.21	Net Sales	3

	1.22	OA	3

	1.23	OP	3

	1.24	Option	3

	1.25	P&G Indemnitees	3

	1.26	P&G Invention	3

	1.27	P&G Know-How	3


		-i-		*Confidential Treatment Requested

TABLE OF CONTENTS

(CONTINUED)


			PAGE
	1.28	P&G Patents	3

	1.29	P&G Technology	4

	1.30	Patents	4

	1.31	Phase II	4

	1.32	Phase III	4

	1.33	RC	4

	1.34	Regulatory Agency	4

	1.35	Regulatory Approval	4

	1.36	Research Plan	4

	1.37	Research Program	4

	1.38	Research Term	4

	1.39	Selected Target	4

	1.40	Selected Target Family	4

	1.41	Sequenom Indemnitees	5

	1.42	Sequenom Invention	5

	1.43	Sequenom Know-How	5

	1.44	Sequenom Patents	5

	1.45	Sequenom Technology	5

	1.46	Term	5

	1.47	Therapeutic License	5

	1.48	Third Party	5

	1.49	US	5

2.	CONDUCT OF RESEARCH PROGRAM		5

	2.1	Conduct of Research Program	5

	2.2	Disclosure of Information Regarding Selected Targets to P&G	5

	2.3	Designation of Selected Targets	6

	2.4	Research Program Responsibilities	7

	2.5	Technology Transfer	7


		-ii-		*Confidential Treatment Requested

TABLE OF CONTENTS

(CONTINUED)


			PAGE
	2.6	Research Program Expenses	7

3.	GOVERNANCE		7

	3.1	Research Committee	7

	3.2	Research Committee Functions and Powers	8

	3.3	Information and Reports	8

4.	LICENSES		8

	4.1	Option to License Selected Targets	8

	4.2	License Grants for Research Program	8

	4.3	License Grants to P&G for Development and Commercialization	8

	4.4

End of Preview

Home Intelligence Services Subscriptions News About Us